The University of Maryland Surgical Team Who Performed Historic Xenotransplantation Will Speak in a Plenary Session at the 2022 HFSA Annual Scientific Meeting

Rockville, Md., August 11, 2022 /PRNewswire/ — In January 2022a team of University of Maryland School of Medicine (UMSOM) have successfully implanted a genetically modified porcine heart into a 57-year-old patient with end-stage heart failure, making history and attracting worldwide attention. The patient survived for two months following the first surgery of its kind, which was performed at University of Maryland Medical Center. The results of this revolutionary xenotransplantation surgery will be discussed in detail during the plenary session on Monday Heart xenotransplantation: where we are and where we are going to Annual Scientific Meeting (ASM) of the Heart Failure Society of America (HFSA) on Monday, October 3, 2022.

The session features these exceptional physicians and scientists:

  • Muhammad M. MohiuddinMDProfessor of Surgery and Scientific/Program Director, Cardiac Xenotransplantation Program at UMSOM
  • Bartley P. GriffithMDThomas E. and Alice Marie Hales Emeritus Professor of Transplant Surgery and Clinical Director, Cardiac Xenotransplantation Program at UMSOM
  • Suzanne Josephdoctor, Cardiologist, Associate Professor of Medicine at UMSOM and Head of Section, Advanced Heart Failure and Transplant Cardiology at UMMC
  • Savitri Fedson, MD, MA, Associate Professor, Center for Medical Ethics and Health Policy, Baylor College of Medicine

The session will explore the scientific advances that laid the foundation for this innovative surgery, the clinical translation of xenotransplantation, the detailed review of the case of the first successful human heart xenotransplantation, and broad discussions of the future of xenotransplantation, including clinical potential, challenges and ethical considerations. , and other concepts that clinicians and researchers need to know for future heart failure care.

“We are absolutely thrilled that the team behind one of the most innovative and groundbreaking cardiovascular achievements can share this with us at ASM,” said David LanfearMD, MS, President of the ASM Program and Manager of Advanced Heart Failure and Transplantation at Henry Ford Hospital. “Their incredible work is paving the way for a future of adequate access to heart transplantation for all patients. I anticipate this will be one of our most popular and anticipated sessions at ASM.”

Drs. Fedson, Griffith, Joseph and Mohiuddin will be joined by HFSA ASM Program Co-ChairsDrs. Daniel GaryMD, PhD, and Cheryl WestlakePhD, RN, who will moderate the roundtable during the session.

The HFSA Annual Scientific Meeting will take place September 30-October 3, 2022at Gaylord National Harbor, just outside washington d.c.. This year’s meeting will include three plenary sessions, organized in the morning to launch each programming day. Registration for the meeting is open and a advanced program is available for download. Learn more about the meeting and register at hfsa.org/asm2022.

PICTURES

Download the photos of the speakers online at https://hfsa.org/university-maryland-surgical-team-who-conducted-historic-xenotransplantation-speak-plenary-session

About the Heart Failure Society of America

The Heart Failure Society of America, Inc. (HFSA) represents the premier organized effort by heart failure experts from the Americas to provide a forum for all those interested in research on heart function, heart failure, and heart failure. congestive heart failure (CHF) and patient care. . HFSA’s mission is to provide a platform to improve and expand heart failure care through collaboration, education, innovation, research and advocacy. HFSA members include physicians, scientists, nurses, nurse practitioners, pharmacists, trainees, other healthcare workers and patients. For more information, visit hfsa.org.

Media Contact: Laura Poko, 301-798-4493, ext. 226, [email protected]

SOURCE American Heart Failure Society

Christine E. Phillips